1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Catheters Market Analysis By Product And Segment Forecasts To 2020

The global market for catheters is expected to reach USD 46.05 billion by 2020. Rising demand for minimally invasive procedures and the growing prevalence of diabetes, obesity and cardiovascular diseases is expected to drive market growth over the forecast period. In addition, the introduction of technologically advanced catheters with improved efficacies and the rising market penetration of minimally invasive procedures in emerging Asian markets such as India and China are expected to fuel the future market growth.

Cardiovascular catheters were the largest product segment in 2013, accounting for over 39.0% of total revenue. High prevalence of cardiovascular diseases clubbed with the presence of a large pool of patients with unmet medical needs is a critical factor for cardiovascular catheter growth.

Further Key findings from the study suggest:

North America dominated the overall market in 2013, accounting for over 37% of global revenue. High volumes of minimally invasive and catheterization procedures coupled with the presence of high patient awareness levels and disposable incomes are some of the factors driving catheter demand in the region.

Asia Pacific catheters market is expected to grow at the highest CAGR of 13.5% from 2014 to 2020, owing to high unmet medical needs and the presence of emerging economies with improving healthcare infrastructure such as China and India.

Specialty catheters are expected to be one of the most lucrative segments of this market, majorly owing to a large presence of untapped opportunities in its application segments such as wound drainage and body fluid suction, and are estimated to grow at a CAGR of over 11.0% from 2014 to 2020.

Key industry participants include Boston Scientific Corporation, Abbott Laboratories, Coloplast, Arrow International, Johnson and Johnson, Medtronic Inc. and others.

For the purpose of this study, Grand View Research has segmented the global Catheters market on the basis of product and region:

- Catheters Product Outlook
- Catheters Platforms
- Cardiovascular Catheter
- Urology Catheters
- Intravenous Catheters
- Neurovascular Catheters
- Specialty Catheters
- Catheters Regional Outlook
- North America
- Europe
- Asia Pacific
- RoW

Table Of Contents

Catheters Market Analysis By Product And Segment Forecasts To 2020
Table of Contents

Chapter 1. Executive Summary

1.1. Catheters - Industry Summary and Critical Success Factors (CSFs)

Chapter 2. Catheters Industry Outlook

2.1. Market Segmentation

2.2. Market Size and Growth Prospects

2.3. Catheters Market Dynamics

2.3.1. Market Driver Analysis

2.3.2. Market Restraint Analysis

2.4. Key Opportunities Prioritized

2.5. Industry Analysis - Porter's

2.6. Catheters - Company Market Share Analysis, by Geography, 2013

2.6.1. North America

2.6.2. Europe

2.6.3. Asia Pacific

2.7. Catheters Market PESTEL Analysis, 2012

Chapter 3. Catheters Product Outlook

3.1. Cardiovascular Catheter

3.1.1. Cardiovascular Catheters Market Estimates and Forecasts, 2012 - 2020 (USD Million)

3.2. Urology Catheter

3.2.1. Urology Catheter Market Estimates and Forecasts, 2012 - 2020 (USD Million)

3.3. Intravenous Catheter

3.3.1. Intravenous Catheter Market Estimates and Forecasts, 2012 - 2020 (USD Million)

3.4. Neurovascular Catheter

3.4.1. Neurovascular Catheter Market Estimates and Forecasts, 2012 - 2020 (USD Million)

3.5. Specialty Catheter

3.5.1. Specialty Catheter Market Estimates and Forecasts, 2012 - 2020 (USD Million)

Chapter 4. Catheters Regional Outlook

4.1. North America

4.1.1. Catheters Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)

4.2. Europe

4.2.1. Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)

4.3. Asia Pacific

4.3.1. Catheters Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)

4.4. RoW

4.4.1. Catheters Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)

Chapter 5. Competitive Landscape

5.1. Boston Scientific Corporation

5.1.1. Company Overview

5.1.2. Financial Performance

5.1.3. Product Benchmarking

5.1.4. Strategic Initiatives

5.2. Coloplast

5.2.1. Company Overview

5.2.2. Financial Performance

5.2.3. Product Benchmarking

5.2.4. Strategic Initiatives

5.3. Abbott

5.3.1. Company Overview

5.3.2. Financial Performance

5.3.3. Product Benchmarking

5.3.4. Strategic Initiatives

5.4. Johnson and Johnson

5.4.1. Company Overview

5.4.2. Financial Performance

5.4.3. Product Benchmarking

5.4.4. Strategic Initiatives

5.5. Arrow International Inc.

5.5.1. Company Overview

5.5.2. Financial Performance

5.5.3. Product Benchmarking

5.5.4. Strategic Initiatives

5.6. Smiths Medical

5.6.1. Company Overview

5.6.2. Financial Performance

5.6.3. Product Benchmarking

5.6.4. Strategic Initiatives

5.7. Edwards Life Sciences Corporation

5.7.1. Company Overview

5.7.2. Financial Performance

5.7.3. Product Benchmarking

5.7.4. Strategic Initiatives

5.8. Medtronic Inc.

5.8.1. Company Overview

5.8.2. Financial Performance

5.8.3. Product Benchmarking

5.8.4. Strategic Initiatives

5.9. Rochester Medical Corporation

5.9.1. Company Overview

5.9.2. Financial Performance

5.9.3. Product Benchmarking

5.9.4. Strategic Initiatives

Chapter 6. Methodology and Scope

6.1. Research Methodology

6.2. Research Scope and Assumption

6.3. List of Data Sources


List of Tables

Catheters - Industry summary and Critical Success Factors (CSFs)
Global Catheters Revenue, 2012 - 2020 (USD Million)
Global Catheters Market Revenue by Region, (USD million), 2012 - 2020
Global Cardiovascular Catheters, 2012 to 2020 (USD million)
Global Cardiovascular Catheters Market Revenue by Region, (USD million), 2012 - 2020
Global Urology Catheters, 2012 to 2020 (USD million)
Global Urology Catheters Market Revenue by Region, (USD million), 2012 - 2020
Global Intravenous Catheters, 2012 to 2020 (USD million)
Global Intravenous Catheters Market Revenue by Region, (USD million), 2012 - 2020
Global Specialty Catheters, 2012 to 2020 (USD million)
Global Specialty Catheters Market Revenue by Region, (USD million), 2012 - 2020
Global Neurovascular Catheters, 2012 to 2020 (USD million)
Global Neurovascular Catheters Market Revenue by Region, (USD million), 2012 - 2020
North America Catheters Demand, by Products, (USD million), 2012 - 2020
North America Catheters Market - Company Market Share Analysis, 2013
Europe Catheters Demand, by Products, (USD million), 2012 - 2020
Europe Catheters Market - Company Market Share Analysis, 2013
Asia Pacific Catheters Demand, by Products, (USD million), 2012 - 2020
Asia Pacific Catheters Market - Company Market Share Analysis, 2013
RoW Catheters Demand, by Products, (USD million), 2012 - 2020
RoW Catheters Market - Company Market Share Analysis, 2013

List of Figures

Catheters Market Segmentation
Global Catheters Market Revenue, 2012 - 2020
Catheters Market Dynamics
Catheters Company Market Share Analysis, 2012
Key Opportunities Prioritized
Industry Analysis - Porter's
Catheters PESTEL Analysis, 2012
Global Catheters revenue, by products, (USD million), 2012 - 2020

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects

Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects

  • $ 6995
  • Industry report
  • December 2016
  • by GBI Research

Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects Summary Type 2 diabetes ...

Global Idiopathic Pulmonary Fibrosis Pipeline Analysis, 2016 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

Global Idiopathic Pulmonary Fibrosis Pipeline Analysis, 2016 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • $ 6500
  • Industry report
  • February 2017
  • by P&S Market Research

Pipeline Overview Idiopathic pulmonary fibrosis (IPF) is referred to as progressive and chronic interstitial pneumonia without known cause. Pulmonary fibrosis is a disease in which tissue profound in lungs ...

Anthocyanins Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2021

Anthocyanins Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2021

  • $ 5795
  • Industry report
  • November 2016
  • by Transparency Market Research

Global Anthocyanins Market: Overview Consumption of anthocyanin rich foods is directly proportional to the reduced incidences of cardiovascular diseases. According to Iowa Women’s Health Study, and approximate ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.